Summary
: It is very useful for the treatment of peptic ulcerations. Many investigators have mentioned that the antiviral and anti-tumor effects of cimetidine depend on inhibition of the activity of suppressor T -cells (Osband et al. 1981; Mavlight and Talpaz, 1984) . However, in the present experiments, ranitidine, famotidine and roxatidine acetate which belong to the same group of histamine H2-receptor antagonists did not show any antiviral effects (Kabuta and Shingu, 1987) . NK cells are defined phenotypically as large granular lymphocytes that express both the antigen CD16 (Leu -11) and NKH -1 (Leu -19) . NK cells may be defined functionally as cells that mediate non -histocompatibility -restricted cytotoxicity against a variety of cell targets, including tumor and virus infected cells. NK cell activities in tumor-bearing mice or HSV -2 infected mice were decreased in comparison with healthy mice (Fitzgerald et al. 1985; Kikuchi et al. 1985) . This paper describes the activation of NK cells by cimetidine. 95 KABUTA, ET AL.
Materials and Methods

Mice
Five week-old BALB/c and beige mice bred in the animal center of Kurume University were used.
Cells
African green monkey kidney (GMK) cells were used for virus growth and titration.
YAC -1 cells, Moloney virus-induced lymphoma cells in A/Sn mice, were used as target cells for NK activity.
Eff ector cells were isolated from the spleens of healthy mice. NK cells were separated by lymphoprep density sedimentation, and adherent cells were removed.
Virus HSV -2 (strain UW -268), GD -VII and VSV were used. 5.5 x 105 PFU/0.5 ml of HSV-2 were inoculated, i. p., into the mice. Fig. 1 indicates the survival ratios in the cimetidine and control groups. Five week-old BALB/c mice were injected, intraperitoneally, with 5.5 x 10 5 PFU/0.5 ml of HSV -2 or GD -VI or VSV and 0.5 mg cimetidine/0.5 ml, simultaneouly.
It was confirmed that cimetidine had no direct effect upon virus inactivation and growth (Kabuta and Shingu, 1987) . Survival ratios of 80% and 85% in the cimetidine groups were significantly greater than the ratios of 10% and 23% observed in the control groups that received a placebo of phosphate buffered saline (PBS). With HSV -2, GD -VI or VSV, the injected mice Fig. 2 shows the effect of cimetidine against the HSV -2 infection in BALB/c mice that were injected with anti-mouse T -serum or anti -asialo GM 1 serum. It was quickly recognized that anti -asialo GM1 inhibits NK cell activity.
The survival duration in mice injected with antiasialo GM1 and cimetidine was shorter than in the control group.
The survival duration in mice injected with anti-mouse T -cell serum was slightly longer in comparison with the control group. Survival ratios in mice injected with anti-mouse T-cell serum and cimetidine were higher in contrast with the anti -asialo GM 1 group or the control group. These results indicate that a suppression of NK cells by anti-asialo GM1 is not affected by cimetidine, but a suppression of T-cells by anti -mouse T -cell serum is affected by cimetidine. Fig. 3 illustrates the effect of cimetidi.ne on the HSV -2 infection in BALB/c mice that were given cyclosporine (0 .25 mg/0.5 ml). It is recognized that cyclosporine inhibits helper T-cells.
After the injection of cyclosporine, the sensitivity of the HSV -2 infection was the same as in the control group. The resistance of the BALB/c mice to the HSV -2 infection KABUTA, ET AL. The 51Cr release in control mice was 9.4%. The per cent lysis at 3 days after cimetidine injection was 43.5%. NK cell activity at 5 and 6 days after cimetidine injection reached peaks of 60.1 and 61.1 %, respectively. In BALB/c mice injected with HSV-2 and cimetidine, the NK cell activity was increased.
NK cell activity in 5 week-old beige mice was low and close to the NK cell activity in 3 week-old BALB/c mice. A detailed paper with respect to NK cell activity is in preparation. The antiviral actions of cimetidine are not well established.
The present data ( Fig. 1) indicates that the effect of cimetidine appears rapidly. Therefore, a reaction related to antibodies can be excluded. Fig. 2 and 3 indicate that the in-I luence of T -cells is negligible.
In Fig. 4 , a small effect of cimetidine seemed to depend on low NK cell activity in beige mice. As shown in Fig. 5 , augmentation and activation of NK cells is initiated by cimetidine injection, and after 3 and 5 days NK cell activity rose to 4.6 and 6.4 times that seen in cotrol mice. Therefore, the antiviral effects of cimetidine appear to depend on NK cell activation. These observations strongly indicate that cimetidine could be a new strategy for successful immunotherapy of viral diseases.
